Researchers work on imaging cancer patients' responses to drugs

10/6/2009 | AsiaOne News

Researchers at the Singapore Bioimaging Consortium's nuclear imaging group are exploring ways to image how drugs are working in cancer patients. They are studying various radioactive markers used in PET and PET/CT imaging, including thymidine tagged with a radioactive fluorine marker. Researchers also are developing a new imaging technique that uses terahertz radiation, a type of radiation that falls between infrared light and microwaves.

View Full Article in:

AsiaOne News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC